Abstract:Most radiogenomics studies focused on identifying imaging phenotypes as a surrogate to mirror a pre-selected set of molecular tumor parameters in cancer patients, which may not fully characterize heterogeneous biological processes within the tumor region, thus compromising the power of radiogenomics to determine prognosis and guide treatment. In this study, we developed a radiogenomics framework to synergistically integrate CT radiomics signatures with gene profiles to predict 1-year early recurrence (ER) and overall survival (OS) in patients with esophageal cancer (EC) receiving concurrent chemoradiation (CRT). Forty-nine patients diagnosed with EC who were treated with CRT were included in this study. All patients received CT scan before therapy and 468 radiomics features were extracted from tumor regions using texture analysis. Related tumor samples obtained via endoscopic biopsy were also used for gene profiling (1046 genes) via exome sequencing technology. The Mann-Whitney test was applied to assess the differences of individual radiomics and genomics features between ER and non-ER groups. The 4-fold cross validation method and the least absolute shrinkage and selection operator (LASSO) regression were employed to select optimal features from both imaging and gene features. Radiomics and genomics signatures were then built separately based on selected features. The multivariable logistic regression was used to construct a radiogenomics model via integrating radiomics with genomics signatures. The utilities of the radiomics signature, genomics signature and radiogenomics model in predicting 1-year ER were evaluated by ROC method individually. The Kaplan-Meier and log-rank tests were also used to evaluate their effectiveness in prediction of OS. Ten radiomics features and thirty gene expression levels showed significant differences between ER and non-ER groups. Two radiomics features (LLH_GLCM_corrm, LHH_GLSZM_SZLGE) and four genomics features (DFFA, LOC101060524, chr9: 67183179-67219393, CT45A8) were optimally selected to build the radiomics and genomics signatures separately, whose individual values in predicting 1-year ER equal to an AUC of 0.717 and 0.808, respectively. The radiogenomics model constructed showed an improved predictive value with an AUC of 0.832. Furthermore, the radiomics signature showed no significant value in prediction of OS. Instead, both the genomics signature alone and the radiogenomics model showed a significant predictive capability for OS. A radiogenomics model integrating CT radiomics signature with gene characteristics was established to improve the prediction accuracy of ER and OS in patients with EC, which would direct towards integrative system-based approaches with prognostic implications for personalized RT.

A Radiogenomics Framework To Improve Prediction Of Clinical Outcomes In Patients With Esophageal Cancer Treated With Concurrent Chemoradiotherapy

CT-based radiomics for predicting radio-chemotherapy response and overall survival in nonsurgical esophageal carcinoma

Using Genomics Feature Selection Method in Radiomics Pipeline Improves Prognostication Performance in Locally Advanced Esophageal Squamous Cell Carcinoma-A Pilot Study.

CT-based Radiomic Analysis for Prediction of Treatment Response of Salvage Chemoradiotherapy for Loco-regional Lymph Node Recurrence After Curative Esophagectomy

A Radiomics Strategy Based on CT Intra-Tumoral and Peritumoral Regions for Preoperative Prediction of Neoadjuvant Chemoradiotherapy for Esophageal Cancer

CT-derived radiomic analysis for predicting the survival rate of patients with non-small cell lung cancer receiving radiotherapy

Radiomics model based on contrast-enhanced CT texture features for pretreatment prediction of overall survival in esophageal neuroendocrine carcinoma

CT-Based Radiomics Nomogram May Predict Local Recurrence-free Survival in Esophageal Squamous Cell Carcinoma Patients Receiving Definitive Chemoradiotherapy: A Multicenter Study

Computed Tomography-Based Radiomic Analysis for Prediction of Treatment Response to Salvage Chemoradiotherapy for Locoregional Lymph Node Recurrence after Curative Esophagectomy.

A Radiomics Nomogram for Non-Invasive Prediction of Progression-Free Survival in Esophageal Squamous Cell Carcinoma

MRI and CT Radiomics Features to Predict Overall Survival of Locally Advanced Esophageal Cancer after Definite Chemoradiotherapy

The gap before real clinical application of imaging-based machine-learning and radiomic models for chemoradiation outcome prediction in esophageal cancer: a systematic review and meta-analysis

Positron Emission Tomography-Based Radiomics Features May Be Prognostic Of Outcome In Patients With Esophageal Squamous Cell Carcinoma Treated With Chemoradiation Therapy

CT Radiomics Based on Machine Learning Predicting Pathologic Complete Response after Neoadjuvant Chemoradiotherapy for Esophageal Cancer

Radiomics Signature: A Potential and Incremental Predictor for EGFR Mutation Status in NSCLC Patients, Comparison with CT Morphology.

Radiomics Signature Facilitates Organ-Saving Strategy in Patients with Esophageal Squamous Cell Cancer Receiving Neoadjuvant Chemoradiotherapy.

Integrative radiogenomics analysis for predicting molecular features and survival in clear cell renal cell carcinoma

Exploration of an Integrative Prognostic Model of Radiogenomics Features With Underlying Gene Expression Patterns in Clear Cell Renal Cell Carcinoma

Radiomics nomogram combined with clinical factors for predicting pathological complete response in resectable esophageal squamous cell carcinoma

Prognostic and Incremental Value of Computed Tomography-Based Radiomics from Tumor and Nodal Regions in Esophageal Squamous Cell Carcinoma

CT-based radiomics nomogram for overall survival prediction in patients with cervical cancer treated with concurrent chemoradiotherapy